ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001791412

Nabulsi Azmi

CIK 0001791412 Name as filed on the most recent filing

Filed as Nabulsi Azmi (12)

34 transaction lines · from 12 filings · filed 2020-11-03 to 2025-01-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

34 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-01-21 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 7,886 disposed 6.59 51,956.91 Form 4, filing 0000950170-25-008353
2024-12-19 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,118 disposed 8.00 8,944.00 Form 4, filing 0000950170-24-139063
2024-07-15 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 10,901 disposed 11.72 127,759.72 Form 4, filing 0000950170-24-084186
2023-04-11 Phathom Pharmaceuticals, Inc.
PHAT 		P, Open-market purchase 10,000 acquired 8.26 82,600.00 Form 4, filing 0001209191-23-023989
2022-05-16 Phathom Pharmaceuticals, Inc.
PHAT 		P, Open-market purchase 20,000 acquired 8.16 163,288.00 Form 4, filing 0001209191-22-029453
2021-05-04 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,968 disposed 36.15 71,150.09 Form 4, filing 0001209191-21-030141
2021-05-04 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,400 disposed 37.09 51,921.24 Form 4, filing 0001209191-21-030141
2021-05-04 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,089 disposed 37.86 41,230.52 Form 4, filing 0001209191-21-030141
2021-05-03 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 5,753 disposed 38.59 221,994.46 Form 4, filing 0001209191-21-030141
2021-05-03 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 4,290 disposed 37.85 162,359.77 Form 4, filing 0001209191-21-030141
2021-04-05 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 4,316 disposed 36.37 156,953.93 Form 4, filing 0001209191-21-025456
2021-04-05 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 4,252 disposed 35.66 151,645.45 Form 4, filing 0001209191-21-025456
2021-04-05 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 785 disposed 37.11 29,133.78 Form 4, filing 0001209191-21-025456
2021-04-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 3,405 disposed 37.28 126,926.82 Form 4, filing 0001209191-21-025456
2021-04-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,742 disposed 38.14 66,441.80 Form 4, filing 0001209191-21-025456
2021-03-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 4,833 disposed 46.16 223,079.68 Form 4, filing 0001209191-21-017484
2021-03-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 2,070 disposed 46.23 95,694.65 Form 4, filing 0001209191-21-017484
2021-03-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,600 disposed 45.17 72,275.52 Form 4, filing 0001209191-21-017484
2021-03-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 600 disposed 44.60 26,757.00 Form 4, filing 0001209191-21-017484
2021-03-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 24 disposed 46.73 1,121.52 Form 4, filing 0001209191-21-017484
2021-03-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 3,825 disposed 45.77 175,068.72 Form 4, filing 0001209191-21-017484
2021-03-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,548 disposed 46.05 71,292.99 Form 4, filing 0001209191-21-017484
2021-02-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 6,384 disposed 41.16 262,782.04 Form 4, filing 0001209191-21-007185
2021-02-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 2,700 disposed 40.51 109,373.49 Form 4, filing 0001209191-21-007185
2021-02-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 5,416 disposed 38.09 206,285.15 Form 4, filing 0001209191-21-007185
2020-12-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 4,307 disposed 45.05 194,030.35 Form 4, filing 0001209191-20-061593
2020-12-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 2,995 disposed 45.57 136,482.15 Form 4, filing 0001209191-20-061593
2020-12-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 5,370 disposed 43.99 236,226.30 Form 4, filing 0001209191-20-061593
2020-12-01 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,828 disposed 44.83 81,949.24 Form 4, filing 0001209191-20-061593
2020-11-02 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 14,500 disposed 36.83 534,026.30 Form 4, filing 0001209191-20-056768
2020-01-05 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 1,854 disposed 33.77 62,608.47 Form 4, filing 0001209191-21-001622
2020-01-04 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 7,614 disposed 33.93 258,367.38 Form 4, filing 0001209191-21-001622
2020-01-04 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 4,932 disposed 33.02 162,841.82 Form 4, filing 0001209191-21-001622
2020-01-04 Phathom Pharmaceuticals, Inc.
PHAT 		S, Open-market sale 100 disposed 34.57 3,457.00 Form 4, filing 0001209191-21-001622

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 32
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Nabulsi Azmi, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001791412

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.